Treatment of Transient Neonatal Diabetes Mellitus: Insulin Pump or Insulin Glargine? Our Experience

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/dia.2014.0055PMID 25437016PMCID PMC4241878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes Mellitus, 6q24-Related Transient Neonatal

  2015influential reference
• Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births

  2011cited by this paper
• Treatment of transient neonatal diabetes mellitus with subcutaneous insulin glargine in an extremely low birth weight neonate.

  2011influential reference
• Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment

  2011influential reference
• Neonatal diabetes and insulin pump therapy

  2010cited by this paper
• Diabetes increases brain damage caused by severe hypoglycemia.

  2009cited by this paper
• Neonatal diabetes mellitus.

  2008cited by this paper
• Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

  2008cited by this paper
• Insulin pump therapy in neonatal diabetes.

  2007cited by this paper
• Diabète néonatal : une maladie aux multiples mécanismes

  2007cited by this paper
• Overview of neonatal diabetes.

  2007cited by this paper
• [Neonatal diabetes: a disease linked to multiple mechanisms].

  2007cited by this paper
• Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants.

  2007cited by this paper
• Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool‐aged children with type 1 diabetes

  2006cited by this paper
• Neonatal diabetes mellitus: Insulin pump as an alternative management strategy

  2005influential reference
• A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.

  2005cited by this paper
• Neonatal Diabetes Mellitus: Patient Reports and Review of Current Knowledge and Clinical Practice

  2005cited by this paper
• Continuous subcutaneous insulin infusion in neonatal diabetes mellitus

  2004cited by this paper
• Developmental pharmacology--drug disposition, action, and therapy in infants and children.

  2003cited by this paper
• Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta‐analysis

  2003cited by this paper
• Permanent diabetes mellitus in the first year of life

  2002cited by this paper
• Ultralente insulin treatment of transient neonatal diabetes mellitus.

  1996cited by this paper
• Long-term course of neonatal diabetes.

  1995cited by this paper
• Pediatric pharmacology: Therapeutic principles in practice

  1980cited by this paper
• Transient diabetes mellitus in a neonate. Evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion.

  1977cited by this paper
• Neonatal diabetes mellitus

  1973influential reference

• Effective use of saline-diluted subcutaneous glargine in very low birth weight babies with neonatal hyperglycemia

  2025influential citation
• Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series

  2024cites this paper
• Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review

  2024cites this paper
• A review of current and prospective treatments for channelopathies, with a focus on gene and protein therapy.

  2023cites this paper
• Recent Advances in Neonatal Diabetes

  2020cites this paper
• DMSO_A_198932 355..364

  2020cites this paper
• Comments on “Comparative Efficacy and Safety of Intermediate-acting, Long-acting and Biosimilar insulins for Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis” by Tricco et al (Dec 2018)

  2019cites this paper
• A Review on Diabetes Mellitus: Current Update on Management and Treatment

  2018cites this paper
• Genetic causes and treatment of neonatal diabetes and early childhood diabetes.

  2018cites this paper
• Transient neonatal diabetes in extremely low-birth-weight baby treated with long-acting insulin (Glargine)

  2018cites this paper
• Transient Neonatal Diabetes Mellitus: A Challenge and Opportunity for Specialized Nursing Care

  2017cites this paper
• A Novel KCNJ11 Mutation Associated with Transient Neonatal Diabetes

  2017cites this paper
• Insulin therapy in neonatal diabetes mellitus: a review of the literature.

  2017cites this paper
• Transient Neonatal Diabetes due to a Mutation in KCNJ11 in a Child with Klinefelter Syndrome

  2017cites this paper
• Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis

  2016cites this paper